Janikova, Andrea <br/><br/>
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?  [electronic resource] 

 -  Leukemia & lymphoma  2015 
 - 2350-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2014.990010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy<br/>Combined Modality Therapy<br/>Czech Republic--epidemiology<br/>Databases, Factual<br/>Female<br/>Humans<br/>Lymphoma, Follicular--epidemiology<br/>Male<br/>Middle Aged<br/>Mortality<br/>Neoplasm Staging<br/>Radiotherapy--methods<br/>Rituximab--therapeutic use<br/>Standard of Care<br/>Treatment Outcome